PHACTS provides the most innovative and technologically advanced products including Pharmogistics® Inventory Management Software that can work with new or existing carousels or as a software only solution. And, to ensure that barcodes are available on all doses of oral solid medications, they offer the PharmoPack® Medication Packaging and Bar-coding system. Their unique MedRexStat Interface Engine is included with all of their products and builds interfaces in minutes saving dozens of hours of valuable Hospital IT time. To obtain additional information, visit www.phacts.net.
Members to Benefit from New Agreement Between Amerinet and Roche Diagnostics
Ad Statistics
Times Displayed: 115097
Times Visited: 6838 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Amerinet Inc., a leading national healthcare group purchasing organization, announces a new agreement with Roche Diagnostics for urinalysis instruments, reagents and services.
Effective July 1, 2010, through, June 30, 2013, the contract offers significant savings to Amerinet members on products including Urisys 1100, Urisys 1800, Urisys 2400 and Criterion II Urine analyzers along with related reagents and supplies.
About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.
About Amerinet
As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and alternate care providers to reduce costs and improve quality through its performance solutions. Built on a foundation of data, savings and trust, and supported by a team of clinical and supply chain experts, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about the Amerinet difference, visit www.amerinet-gpo.com.
Back to HCB News
